The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease.
• The germinal center (GC) B-cell-like (GCB) and non-GCB subtypes have distinct clinical behaviors.
• Understanding prognostic markers is crucial for optimizing DLBCL treatment.

Purpose of the Study:

• To evaluate the non-germinal center (GC) profile as a prognostic marker for treatment response and survival in DLBCL.
• To compare characteristics of GC and non-GC DLBCL patients receiving chemoimmunotherapy.
• To assess the independent value of the non-GC profile in multivariate analyses.

Main Methods:

• Patient-level meta-analysis of retrospective data from 712 newly diagnosed DLBCL patients.
• Treatment regimens included rituximab-containing chemoimmunotherapy.
• GC and non-GC profiles were determined using the Hans algorithm.

Main Results:

• The non-GC profile showed a trend towards worse overall and progression-free survival, but this did not reach statistical significance in multivariate analysis.
• The non-GC profile was independently associated with significantly lower complete response rates (p<0.01).
• A higher proportion of GC DLBCL was observed in Asian patients (p=0.01).

Conclusions:

• The non-GC profile is an independent predictor of inferior complete response rates in DLBCL patients treated with chemoimmunotherapy.
• While a trend towards poorer survival was noted, the non-GC profile did not independently predict survival in this meta-analysis.
• Ethnic differences in GC DLBCL prevalence warrant further investigation.